Achieving Digitization: The Importance of Data Integrity in Pharma’s Digital Revolution
More from R&D
With no advances for decades, the STI could soon be facing two new antibiotic threats, while a third novel therapy has just entered the clinic.
The firm is concentrating on its Keytruda combo for head and neck cancer after being abandoned by Roche and boardroom battles.
In this series of articles, we look at different mechanisms of actions beyond GLP-1s that could determine the obesity drug landscape in the coming years. After exploring the potential of amylin receptor agonists, we now look at myostatins, which analysts expect to generate peak sales of $30bn.
The drugmaker announced topline results from the Phase III ATTAIN-2 trial in overweight/obese patients with type 2 diabetes and plans to file for approval.
More from Scrip
Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies
Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies
Insights from Novotech on Evolving Trends Impacting Global Clinical Development

Lonza is addressing the growing global demand for biologics by utilizing its expert teams and the advanced capabilities of its newly acquired large-scale manufacturing site in Vacaville, California. Joanna McCafferty, Director of Commercial Development, shares more in this brief video. Ask ChatG